Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Continuous Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced/Metastatic Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07689812
Title field or adapter rule
{'original_value': 'A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Continuous Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced/Metastatic Solid Tumors', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:29.730742+00:00
Published At
2026-10-27T00:00:00+00:00
Record Updated At
2026-10-27
Source Retrieved At
2026-10-31T22:19:02.163121+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["NSCLC (Advanced Non-small Cell Lung Cancer)", "NSCLC (Non-small Cell Lung Cancer)", "NSCLC (Non-small Cell Lung Carcinoma)", "NSCLC", "Melanoma (Skin Cancer)", "Melanoma (Skin) Stage IV", "CRC", "MSI High Colorectal Cancer", "DMMR Colorectal Cancer", "RCC, Renal Cell Cancer", "RCC", "Solid Tumors", "Metastatic Solid Tumors", "Advanced Solid Tumors", "Advanced Solid Tumors Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-27", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT07689812"
protocolSection.identificationModule.officialTitle
"A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Continuous Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced/Metastatic Solid Tumors"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • NSCLC (Advanced Non-small Cell Lung Cancer) (protocolSection.conditionsModule.conditions)
  • NSCLC (Non-small Cell Lung Cancer) (protocolSection.conditionsModule.conditions)
  • NSCLC (Non-small Cell Lung Carcinoma) (protocolSection.conditionsModule.conditions)
  • NSCLC (protocolSection.conditionsModule.conditions)
  • Melanoma (Skin Cancer) (protocolSection.conditionsModule.conditions)
  • Melanoma (Skin) Stage IV (protocolSection.conditionsModule.conditions)
  • CRC (protocolSection.conditionsModule.conditions)
  • MSI High Colorectal Cancer (protocolSection.conditionsModule.conditions)
  • DMMR Colorectal Cancer (protocolSection.conditionsModule.conditions)
  • RCC, Renal Cell Cancer (protocolSection.conditionsModule.conditions)
  • RCC (protocolSection.conditionsModule.conditions)
  • Solid Tumors (protocolSection.conditionsModule.conditions)
  • Metastatic Solid Tumors (protocolSection.conditionsModule.conditions)
  • Advanced Solid Tumors (protocolSection.conditionsModule.conditions)
  • Advanced Solid Tumors Cancer (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['SOC Continuous ICI', 'ctDNA-Guided Intermittent ICI'], 'description': 'The test is used to monitor for disease recurrence.', 'name': 'Signatera Genome ultra-sensitive ctDNA blood test', 'type': 'DEVICE'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.